计算机事件点评：Neuralink量产在即，国产脑机链有望充分受益

Investment Rating - The industry investment rating is "Recommended" (maintained) [1] Core Insights - Neuralink is set to begin large-scale production in 2026, transitioning to a more streamlined and fully automated surgical process [7] - The brain-computer interface (BCI) market is projected to reach approximately $3.19 billion by 2025, with significant growth expected in medical applications, potentially reaching $40 billion by 2030 and $145 billion by 2040 [9] - The Chinese BCI market is anticipated to exceed 3.8 billion yuan by 2025, with a compound annual growth rate of around 20% [10] - The report emphasizes the strong demand in the medical sector, particularly for spinal cord injury rehabilitation, and the increasing interest in consumer electronics and industrial applications [10] Summary by Sections Industry Performance - The computer industry has shown a relative performance of 5.7% over the last month, -3.9% over the last three months, and 33.3% over the last year, outperforming the CSI 300 index [5] Investment Highlights - Neuralink aims to achieve full human-AI connectivity through its three product lines, with plans to increase electrode counts significantly by 2028 [8] - The report identifies key applications such as telepathy for motor function disorders, blindsight for visual reconstruction, and deep brain stimulation for neurological conditions [9] Policy and Technological Support - The Chinese government has established a comprehensive support system for the BCI industry, with initiatives aimed at fostering innovation and establishing a competitive ecosystem by 2030 [11] - Significant technological advancements have been made in the BCI field, including successful clinical trials and innovations in both invasive and non-invasive technologies [12] Related Companies - The report highlights several companies that are expected to benefit from the growth in the BCI sector, including Yanshan Technology, Entropy Technology, and others [12]